Handok terminates partnership with Sanofi-Aventis

Published: 2012-09-28 06:59:00

Updated: 2012-09-28 06:59:00

Handok Pharmaceutical is ending its longstanding alliance with Japan’s Sony on their joint LCD venture, after both companies deciced to seek the independent management objectives for racking up their long-term growth.

“Handok has agreed with Sanofi-Aventis to buy its entire stake in the joint ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK